Abstract

Formation of a partition complex on plasmid F by binding of SopB protein to the sopC centromere is the first step in the partition process that ensures stability of F in dividing cells. Establishment of the complex enables nonspecific binding of SopB to neighboring DNA, which extends the partition complex and provokes reduction of negative supercoiling of the plasmid. This reduction is believed to reflect winding of DNA into positive supercoils about SopB to create a nucleoprotein structure of probable importance to partition. We have searched for evidence that SopB alters plasmid topology. Permutation analysis indicated only modest bending of linear DNA fragments, and in vivo DNase I footprinting revealed no enhanced cleavages indicating curvature. In vitro, SopB binding left no topological trace in relaxed-circular DNA treated with topoisomerase I or in nicked circles closed by ligase. In vivo, novobiocin-mediated inhibition of DNA gyrase relaxed a plasmid carrying the partition complex but left no residue of positive supercoils. Hence, SopB does not reduce plasmid supercoiling directly. We did observe that SopB partly prevented removal of negative supercoils from plasmid DNA by topoisomerase I and partly prevented ligation of nicked circles, indicating that it acts as a physical obstacle. The supercoil deficit is thus better explained as SopB recoating of just-replicated DNA, which shelters it from gyrase and from topological changes in SopB-free DNA. This topological simplicity distinguishes the Sop partition complex from other complexes described.

Highlights

  • Operon, parAB, to which the centromere is usually adjacent

  • While we do not yet know to what extent the structural features so far identified are exploited in vivo, it is clear that defining partition complex structure will be necessary for understanding events at the ParA-partition complex interface

  • Restriction and nicking endonucleases, T4 DNA ligase, T4 polynucleotide kinase (PNK), Klenow fragment of DNA polymerase I, and Taq polymerase were purchased from New England Biolabs, calf thymus topoisomerase I (Topo I)2 from Invitrogen, and oligonucleotides, bovine serum albumin (Fraction V), chloroquine and Sybr green from Sigma

Read more

Summary

EXPERIMENTAL PROCEDURES

Enzymes, and Reagents—SopB was purified as described previously [21]. Restriction and nicking endonucleases, T4 DNA ligase, T4 polynucleotide kinase (PNK), Klenow fragment of DNA polymerase I, and Taq polymerase were purchased from New England Biolabs, calf thymus topoisomerase I (Topo I) from Invitrogen, and oligonucleotides, bovine serum albumin (Fraction V), chloroquine and Sybr green from Sigma. Filter Binding Assay—SopB DNA binding activity was assayed by double filter binding as previously described [21]. The specific and nonspecific DNA species were, respectively, a 144-bp sopCϩ fragment produced by PCR amplification from

The abbreviations used are
RESULTS
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.